GlassScriptPhysician profile
Charles Bigajer
NPI 1679652119
$3,736.52
in general payments reported to CMS, 2019-2025
38 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $247 · 2021: $708 · 2022: $883 · 2023: $524 · 2024: $327 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $662.96 | 2019-2023 | Xifaxan |
| Abbvie INC. | $365.39 | 2019-2025 | |
| Shionogi INC | $345.16 | 2021-2023 | Fetroja |
| Insmed, INC. | $297.95 | 2020-2023 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.58 | 2019-2025 | |
| Gilead Sciences, INC. | $214.74 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $160.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $116.33 | 2020-2022 | |
| Baxter Healthcare | $110.94 | 2022-2024 | Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Hospital Products INC. | $94.27 | 2021-2025 | Acthar |
| Vapotherm INC | $86.73 | 2021-2023 | Vapotherm |
| Merck Sharp & Dohme LLC | $79.76 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $73.90 | 2019-2022 | |
| Glaxosmithkline, LLC. | $65.57 | 2021-2023 | Nucala |
| Pfizer INC. | $59.75 | 2019-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bigajer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.